Test Price
2,800 AED✅ Home Collection Available
NOL3 Gene Familial Cortical Myoclonus Genetic Test in UAE | 2,800 AED | DHA-Licensed Precision Diagnostics
Executive Summary & Core Metrics
Precision Genetic Analysis for Familial Cortical Myoclonus
This advanced genetic test employs Next-Generation Sequencing (NGS) of the NOL3 gene to detect pathogenic variants associated with familial cortical myoclonus. Clinical oversight provided by our Consultant Medical Genetics team led by Lina Osama Zaki Quteineh (DHA Registration ID: 9294403).
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Genetic Counselling with a DHA-licensed genetic counselor.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The NOL3 gene test utilizes Next-Generation Sequencing (NGS) to identify pathogenic variants associated with familial cortical myoclonus, a rare neurological movement disorder. This detailed genetic analysis is essential for confirming clinical diagnosis, guiding antiepileptic therapy, and providing accurate genetic counselling for affected families.
Pre-Test Requirements
- Detailed clinical history of myoclonus or epilepsy with a documented family pedigree.
- Mandatory pre-test genetic counselling session to construct a three-generation pedigree chart of affected and at-risk family members.
- Sample: Whole blood (3–5 mL in EDTA), extracted DNA, or one drop of blood on an FTA card.
All collection performed by DHA-licensed phlebotomists under temperature-controlled cold-chain protocols.
Comparative Advantage: NGS vs. Sanger Sequencing
| Feature | Our Test (NGS Precision) | Closest Alternative (Sanger Sequencing / Panel) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene coverage with deletion/duplication analysis | Single-gene Sanger sequencing; limited to point mutations |
| Diagnostic Sensitivity | 99.9% | ~85–90% |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Home Collection | VIP Mobile Phlebotomy & Cold-Chain Logistics | Hospital-only draw |
| Genetic Counselling | Included pre- and post-test | Often separate referral |
| Accreditation | ISO 9001:2015, DHA Licensed Facility (No. 1143) | Variable |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I recognize the diagnostic challenges that familial cortical myoclonus presents in clinical practice. This comprehensive NOL3 gene analysis provides definitive molecular evidence to confirm the diagnosis, enabling precise genetic counselling and informed family planning. I always emphasize that genetic test results should be interpreted within the full clinical context, as the presence of a pathogenic variant does not invariably predict disease severity or progression.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not alter, pause, or discontinue any prescribed antiepileptic or other medication without direct consultation with your treating physician. Abrupt changes may precipitate seizure recurrence or other serious adverse events.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals experiencing acute medical instability or requiring emergency intervention for uncontrolled seizures are not candidates for outpatient genetic testing.
- Exclusion: Informed consent must be obtained from the patient or legal guardian in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Red Flag – Immediate Emergency Care Required: Sudden escalation of myoclonic jerks accompanied by loss of consciousness, prolonged seizure activity lasting more than five minutes, or signs of respiratory compromise.
Patient FAQ & Clinical Guidance
1. What exactly does this NOL3 gene test detect?
This NGS-based test identifies pathogenic mutations in the NOL3 gene responsible for familial cortical myoclonus with high precision. It also detects deletions and duplications that standard sequencing may miss, providing a comprehensive molecular diagnosis.
2. How is the sample collected and is it painful?
A certified phlebotomist collects a small blood sample (3–5 mL in an EDTA tube) via a routine venipuncture during a scheduled home visit. The procedure is minimally invasive and typically causes only brief discomfort. Alternatively, you may provide a buccal swab or an existing extracted DNA sample.
3. How long do results take and how will I receive them?
Results are typically available within 3 to 4 weeks. A detailed genetic report is issued by our DHA-licensed laboratory, and a telephonic post-test counselling session with a genetic counselor is scheduled to explain the findings and their clinical implications.
4. Does a positive result mean I will definitely develop symptoms?
Not necessarily. A pathogenic variant indicates increased risk but does not guarantee disease onset or severity. Penetrance and expressivity vary widely, which is why ongoing clinical correlation with a neurologist is essential. Genetic counselling helps contextualize your individual risk.
UAE Regulatory & Data Privacy Adherence
Your data is protected under UAE law. This test and all associated health information are processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. These frameworks ensure strict confidentiality, purpose limitation, and secure storage of your genomic and clinical data. Our laboratory is ISO 9001:2015 certified and holds DHA Facility License No. 1143, affirming our commitment to the highest standards of quality and data governance.
Clinical & Logistical Metadata
| Test Name | NOL3 Gene Familial Cortical Myoclonus Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with Deletion/Duplication Analysis |
| ICD-10-CM Code | G25.3 |
| LOINC Code | 21631-7 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians